SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,230,000 | +64.0% | 82,140 | +33.3% | 0.17% | +64.1% |
| Q1 2016 | $750,000 | -6.2% | 61,630 | +87.4% | 0.10% | -21.4% |
| Q2 2015 | $800,000 | +22.7% | 32,889 | +30.5% | 0.13% | +8.3% |
| Q2 2014 | $652,000 | +107.0% | 25,197 | +86.7% | 0.12% | +28.7% |
| Q1 2014 | $315,000 | +44.5% | 13,497 | +57.0% | 0.09% | +4.4% |
| Q4 2013 | $218,000 | -65.0% | 8,597 | -71.8% | 0.09% | -71.6% |
| Q3 2013 | $622,000 | -4.6% | 30,480 | -1.9% | 0.32% | -24.3% |
| Q2 2013 | $652,000 | – | 31,080 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |